- Home
- APLS vs RLX Comparison
APLS vs RLX Comparison
Compare APLS & RLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$20.00
HOLD
Current Price
$2.30
Company Overview
Basic Information| Metric | APLS | RLX |
|---|---|---|
| Founded | 2009 | 2018 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 2.8B |
| IPO Year | 2017 | 2021 |
Fundamental Metrics
Financial Performance| Metric | APLS | RLX |
|---|---|---|
| Price | $20.00 | $2.30 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 20 | 1 |
| Target Price | ★ $33.58 | $2.25 |
| AVG Volume (30 Days) | ★ 2.8M | 1.8M |
| Earning Date | 02-27-2026 | 11-14-2025 |
| Dividend Yield | N/A | ★ 4.76% |
| EPS Growth | N/A | ★ 19.33 |
| EPS | ★ 0.36 | 0.08 |
| Revenue | ★ $1,016,397,000.00 | $459,694,770.00 |
| Revenue This Year | $28.88 | $60.60 |
| Revenue Next Year | N/A | $26.16 |
| P/E Ratio | $55.68 | ★ $27.85 |
| Revenue Growth | 42.11 | ★ 51.58 |
| 52 Week Low | $16.10 | $1.66 |
| 52 Week High | $31.17 | $2.84 |
Technical Indicators
Market Signals| Indicator | APLS | RLX |
|---|---|---|
| Relative Strength Index (RSI) | 34.80 | 47.72 |
| Support Level | $20.03 | $2.20 |
| Resistance Level | $27.46 | $2.36 |
| Average True Range (ATR) | 1.43 | 0.06 |
| MACD | -0.74 | 0.00 |
| Stochastic Oscillator | 3.05 | 52.63 |
Price Performance
Historical Comparison APLS
RLX
About APLS Apellis Pharmaceuticals Inc.
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.
About RLX RLX Technology Inc. each representing the right to receive one (1) ordinary share
RLX Technology Inc is engaged in the manufacturing of e-vapor products for adult smokers. It has an integrated offline distribution and "Branded store plus" retail model tailored to China's e-vapor market.